Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cross-reactivity

Cross-reactivity

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mpox Seroprevalence among Sex Workers and Men who have Sex with Men Preceding Sustained Urban Outbreak in the Democratic Republic of the Congo.

Epidemiology and infection·2026

Same author

Bundibugyo Ebola in DR Congo and Uganda: community-centred response must be operational, not rhetorical.

The Lancet. Infectious diseases·2026

Same author

Mpox: virus expansion, evolution, and immune recognition.

The Lancet. Infectious diseases·2026

Same author

Implementation of a One Health Surveillance System in the Democratic Republic of the Congo.

EcoHealth·2026

Same author

Assessing mpox knowledge and sexual behaviours within high-risk populations in the Democratic Republic of the Congo.

BMJ global health·2026

Same author

Dropout from the pentavalent vaccine series among children aged 12-23 months in the Central African Republic: prevalence, associated factors, and caregiver-reported barriers.

Vaccine·2026

Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026

Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026

Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026

Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026

Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026

Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 26, 2026

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Whither monkeypox vaccination.

Anne W Rimoin¹, Barney S Graham

¹University of California, Los Angeles School of Public Health, Los Angeles, CA, USA.

|December 23, 2011

Summary

This summary is machine-generated.

Monkeypox (MPX) vaccination decisions are complex. Factors influencing vaccine trials and programs for this rising viral threat, despite low incidence, are considered.

Keywords:

Orthopoxvirus biodefense smallpox vaccine variola

More Related Videos

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Related Experiment Videos

Last Updated: May 26, 2026

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Area of Science:

Virology
Epidemiology
Public Health

Background:

Monkeypox (MPX) is a virulent orthopoxvirus endemic in Central Africa.
MPX incidence has increased following the discontinuation of smallpox immunization.
Current cases are geographically restricted and spread is limited, posing logistical challenges.

Purpose of the Study:

To analyze factors influencing decisions regarding MPX vaccination.
To evaluate the feasibility of vaccine trials and implementation programs.

Main Methods:

Literature review on MPX epidemiology and virology.
Analysis of factors affecting vaccine trial logistics and public health interventions.

Main Results:

Limited person-to-person spread and low overall incidence complicate vaccine trial design.
Geographic isolation of endemic areas presents accessibility challenges for vaccination programs.
The rising incidence necessitates careful consideration of vaccination strategies.

Conclusions:

Decisions on MPX vaccination require balancing disease severity against logistical and epidemiological challenges.
Further research is needed to determine the optimal approach for MPX prevention.
Careful consideration of various factors is crucial before pursuing widespread MPX vaccination.